CRKL silencing inhibits melanoma growth and enhances its chemotherapy sensitivity through the PI3K/AKT and NLRP3/GSDMD pathways

作者：Jiashe Chen, Mingyuan Xu, Fei Wu, Fei Wu, Nanhui Wu, Jie Li, Yongyi Xie, Ruoqi Wang, Ningyuan Xi, Yueyi Zhu, Xiaoxiang Xu, Yeqiang Liu · 发表于：Biochemical Pharmacology · 年份：2025 · DOI：10.1016/j.bcp.2025.116840 · 被引用次数：6 · 研究领域：Endoplasmic Reticulum Stress and Disease、Inflammasome and immune disorders、Cell death mechanisms and regulation